Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Campath litigation germany?When is the expected fda decision date for apotex's ruxolitinib resubmission?Children's ibuprofen price?What's the impact of mixing lipitor bp meds negatively?Defense strategy against generic in niche market?
See the DrugPatentWatch profile for Alecensa
Alecensa is the brand name of alectinib, a prescription cancer medicine made by Astellas Pharma in collaboration with partner supply/manufacturing networks.
In the US, Alecensa is marketed under the Astellas Pharma brand, which is also the company listed with the product.
Alecensa is produced through a global manufacturing supply chain, so the drug may be manufactured at facilities operated by different contract manufacturers. The marketing/holder of the branded product, however, is associated with Astellas Pharma.
Alecensa (alectinib) is used to treat certain patients with ALK-positive metastatic non-small cell lung cancer (NSCLC), where the tumor has the ALK gene rearrangement.
Other Questions About Alecensa :